Related Experiment Video
Updated: Jun 7, 2026

Vagus Nerve Stimulation as a Tool to Induce Plasticity in Pathways Relevant for Extinction Learning
Published on: August 21, 2015
Transcutaneous auricular vagus nerve stimulation for dysphagia in acute stroke: a randomized sham-controlled trial
Fioravante Capone1, Fabio Pilato1, Francesco Motolese2
1Department of Medicine and Surgery, Unit of Neurology, Neurophysiology, Neurobiology, and Psychiatry, Università Campus Bio-Medico di Roma, Via Alvaro del Portillo, 21, Roma, 00128, Italy; Unit of Neurology, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, Roma, 00128, Italy.
Background:
Post-stroke dysphagia (PSD) is a frequent and debilitating complication that affects stroke patients and is strongly associated with relevant morbidity and increased mortality. Current PSD rehabilitation strategies are only partially effective, and fewer than 20% of patients return to their pre-stroke diet. Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive neuromodulation technique capable of enhancing neuroplasticity through activation of brainstem vagal nuclei, including the nucleus tractus solitarius, which plays a central role in the swallowing pattern generator. Preliminary human and animal studies suggest that taVNS may augment motor recovery and exert neuroprotective effects in the acute stroke phase. This study investigated whether taVNS combined with swallowing rehabilitation improves PSD outcomes when administered within the first week after stroke.
Methods:
This was a parallel-group, superiority, randomized, double-blind, sham-controlled trial including 30 acute stroke patients (ischemic or haemorrhagic) with dysphagia confirmed by fiberoptic endoscopic evaluation (FEES). Participants were randomized to real or sham taVNS delivered simultaneously with standardized swallowing therapy for three consecutive days. Swallowing function was assessed at baseline (T0), after the intervention (T1), and at 3 months (T2) using FEES-derived validated scales. Neurological disability (NIHSS, mRS), medical complications, and mortality were also recorded. Primary analysis used repeated-measures ANOVA.
Results:
Compared to sham, the real taVNS group demonstrated greater improvements from T0 to T1 across all swallowing measures (FEDSS [p = 0.024], DOSS [p = 0.022], PAS [p = 0.018], P-score [p = 0.008], and FOIS [p = 0.021]), with effects persisting at T2 for FEDSS (p = 0.046). Length of stay in Stroke Unit was shorter in the real group (5.9 ± 2.8 vs 11.3 ± 8.7 days, p = 0.002). No serious adverse events occurred.
Conclusions:
Early taVNS, paired with swallowing rehabilitation, was associated with improvements in dysphagia recovery, in acute stroke. This short, safe intervention may accelerate functional improvement and could represents a promising adjunctive therapy for PSD.
Registration:
URL: https://clinicaltrials.gov; Unique identifier: NCT06827301.
More Related Videos
06:31Laboratory Administration of Transcutaneous Auricular Vagus Nerve Stimulation (taVNS): Technique, Targeting, and Considerations
Published on: January 7, 2019
04:04Transauricular Vagus Nerve Stimulation and Electroencephalographic Assessment in Disorders of Consciousness
Published on: July 11, 2025